Hisamitsu Pharmaceutical Co., Inc. revenue reports
Hisamitsu Pharmaceutical Co., Inc. financial reports, Hisamitsu Pharmaceutical Co., Inc. annual revenue in 2024. When does Hisamitsu Pharmaceutical Co., Inc. report revenue?
Hisamitsu Pharmaceutical Co., Inc. total revenue, net income and dynamics of changes in US dollar today
Hisamitsu Pharmaceutical Co., Inc. current income and income for the latest reporting periods. Hisamitsu Pharmaceutical Co., Inc. net revenue for today is 35 677 000 000 $. Here are the main financial indicators of Hisamitsu Pharmaceutical Co., Inc.. The financial graph of Hisamitsu Pharmaceutical Co., Inc. shows the values and changes of such indicators: total assets, net income, net revenue. The financial report chart on our website displays information by dates from 28/02/2019 to 30/11/2019. The value of Hisamitsu Pharmaceutical Co., Inc. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/11/2019
35 677 000 000 $
-
7 872 000 000 $
-
31/08/2019
34 168 000 000 $
-
5 635 000 000 $
-
31/05/2019
29 233 000 000 $
-
1 913 000 000 $
-
28/02/2019
40 834 000 000 $
-
5 875 000 000 $
-
Show:
to
Hisamitsu Pharmaceutical Co., Inc. financial report charts
The latest dates of Hisamitsu Pharmaceutical Co., Inc. financial statements available online: 28/02/2019, 31/08/2019, 30/11/2019. The dates of the financial statements are determined by the accounting rules. The latest financial report of Hisamitsu Pharmaceutical Co., Inc. is available online for such a date - 30/11/2019. Gross profit Hisamitsu Pharmaceutical Co., Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Hisamitsu Pharmaceutical Co., Inc. is 24 015 000 000 $
Hisamitsu Pharmaceutical Co., Inc. quarterly report dates
Cost of revenue Hisamitsu Pharmaceutical Co., Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Hisamitsu Pharmaceutical Co., Inc. is 11 662 000 000 $ Total revenue Hisamitsu Pharmaceutical Co., Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Hisamitsu Pharmaceutical Co., Inc. is 35 677 000 000 $ Operating income Hisamitsu Pharmaceutical Co., Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Hisamitsu Pharmaceutical Co., Inc. is 8 228 000 000 $
Net income Hisamitsu Pharmaceutical Co., Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Hisamitsu Pharmaceutical Co., Inc. is 7 872 000 000 $ Current assets Hisamitsu Pharmaceutical Co., Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Hisamitsu Pharmaceutical Co., Inc. is 205 531 000 000 $ Total assets Hisamitsu Pharmaceutical Co., Inc. refers to the total amount of assets owned by a person or entity. Total assets Hisamitsu Pharmaceutical Co., Inc. is 307 986 000 000 $
30/11/2019
31/08/2019
31/05/2019
28/02/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
24 015 000 000 $
22 177 000 000 $
18 332 000 000 $
24 282 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
11 662 000 000 $
11 991 000 000 $
10 901 000 000 $
16 552 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
35 677 000 000 $
34 168 000 000 $
29 233 000 000 $
40 834 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
8 228 000 000 $
7 410 000 000 $
2 780 000 000 $
6 339 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
7 872 000 000 $
5 635 000 000 $
1 913 000 000 $
5 875 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
13 032 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
27 449 000 000 $
26 758 000 000 $
26 453 000 000 $
34 495 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
205 531 000 000 $
200 319 000 000 $
192 461 000 000 $
193 569 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
307 986 000 000 $
296 731 000 000 $
290 121 000 000 $
297 512 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
104 555 000 000 $
108 901 000 000 $
115 710 000 000 $
110 283 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
40 685 000 000 $
36 708 000 000 $
31 490 000 000 $
30 354 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
57 739 000 000 $
51 913 000 000 $
46 820 000 000 $
49 352 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
18.75 %
17.49 %
16.14 %
16.59 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
248 830 000 000 $
243 445 000 000 $
241 938 000 000 $
246 865 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
Last revenue report of Hisamitsu Pharmaceutical Co., Inc. was 30/11/2019. According to last financial report total revenue in Hisamitsu Pharmaceutical Co., Inc. was 35 677 000 000 US dollar and changed by 0% since last year. Net income in Hisamitsu Pharmaceutical Co., Inc. was 7 872 000 000 $ in last quartal, net income changes to 0%.
Current cash Hisamitsu Pharmaceutical Co., Inc. - the sum of all of the cash a company has on the date of report. Current cash Hisamitsu Pharmaceutical Co., Inc. is 104 555 000 000 $ Current debt Hisamitsu Pharmaceutical Co., Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Hisamitsu Pharmaceutical Co., Inc. is 40 685 000 000 $ Total debt Hisamitsu Pharmaceutical Co., Inc. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Hisamitsu Pharmaceutical Co., Inc. is 57 739 000 000 $
Hisamitsu Pharmaceutical Co., Inc. stocks data
HTSUF stock price
Hisamitsu Pharmaceutical Co., Inc. stock price today, HTSUF stock quote.
